Can Newberle Phospholipid Soft Capsules Lower Blood Lipids

Newbella phospholipid soft capsules may help regulate blood lipids, but cannot replace drug therapy. Its main component, soybean phospholipids, may have a certain improvement effect on hyperlipidemia by promoting lipid metabolism. The active ingredients such as phosphatidylcholine contained in soybean phospholipids can help emulsify cholesterol, promote the metabolism of low-density lipoprotein cholesterol, and increase high-density lipoprotein cholesterol levels. Some clinical observations have found that long-term regular use may lead to a decrease in total cholesterol, but the effect varies among individuals. This product is more suitable as an auxiliary means of dietary regulation and is suitable for individuals with mild dyslipidemia. For patients with moderate to severe hyperlipidemia, relying solely on phospholipid soft capsules is difficult to achieve treatment goals. Pathological hyperlipidemia is often associated with abnormal apolipoprotein metabolism and familial hypercholesterolemia, and requires intervention with statin drugs such as atorvastatin calcium tablets and rosuvastatin calcium tablets. If combined with atherosclerosis, antiplatelet therapy such as aspirin enteric coated tablets is also needed.

During the use of Newbella phospholipid soft capsules, regular monitoring of the four indicators of blood lipids should be carried out to avoid co administration with anticoagulant drugs. Daily intake of animal organs and fried foods should be controlled, and dietary fiber intake such as deep-sea fish and oats should be increased. Moderate intensity exercise should be maintained every week. If blood lipids do not improve or liver discomfort occurs after continuous use, seek medical attention promptly to adjust the treatment plan.